Daniel De Schryver is Patient Engagement & Advocacy Lead (EMEA) for Janssen. Daniel is part of a global multi-functional leadership team that helps the company to engage with patients in a systematic way and helps to build partnerships in developing solutions that better meet the existing needs. He also leads a team in the EMEA region who play a crucial role in working towards a more collaborative approach in innovation.
Daniel sat down with PharmaComms.tv during the EyeForPharma Marketing and Customer Innovation European Conference 2019 in London. He spoke to Niall O’Driscoll about the importance of patient input and involvement in the early stages of solution development and throughout the life-cycle in order to deliver better outcomes for patients.